DK0607163T3 - Neuroleptiske 2-substituerede perhydro-1-H-pyrido- 1,2-a pyraziner - Google Patents

Neuroleptiske 2-substituerede perhydro-1-H-pyrido- 1,2-a pyraziner

Info

Publication number
DK0607163T3
DK0607163T3 DK92918074.3T DK92918074T DK0607163T3 DK 0607163 T3 DK0607163 T3 DK 0607163T3 DK 92918074 T DK92918074 T DK 92918074T DK 0607163 T3 DK0607163 T3 DK 0607163T3
Authority
DK
Denmark
Prior art keywords
pct
pyrazines
neuroleptic
pyrido
substituted perhydro
Prior art date
Application number
DK92918074.3T
Other languages
Danish (da)
English (en)
Inventor
Gene Michael Bright
Kishor Amratlal Desai
Thomas Francis Seeger
Teresa Annette Smolarek
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of DK0607163T3 publication Critical patent/DK0607163T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/582Recycling of unreacted starting or intermediate materials

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK92918074.3T 1991-09-25 1992-08-14 Neuroleptiske 2-substituerede perhydro-1-H-pyrido- 1,2-a pyraziner DK0607163T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US76533291A 1991-09-25 1991-09-25

Publications (1)

Publication Number Publication Date
DK0607163T3 true DK0607163T3 (da) 1997-03-17

Family

ID=25073279

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92918074.3T DK0607163T3 (da) 1991-09-25 1992-08-14 Neuroleptiske 2-substituerede perhydro-1-H-pyrido- 1,2-a pyraziner

Country Status (25)

Country Link
US (1) US5565453A (de)
EP (1) EP0607163B1 (de)
JP (1) JPH08827B2 (de)
CN (1) CN1071167A (de)
AT (1) ATE146178T1 (de)
AU (1) AU655071B2 (de)
BR (1) BR9206541A (de)
CA (1) CA2118936A1 (de)
CZ (1) CZ281775B6 (de)
DE (1) DE69215886T2 (de)
DK (1) DK0607163T3 (de)
ES (1) ES2096099T3 (de)
FI (1) FI941377A (de)
GR (1) GR3022483T3 (de)
HU (1) HUT71488A (de)
IL (1) IL103204A (de)
MX (1) MX9205385A (de)
MY (1) MY108303A (de)
NO (1) NO941084L (de)
NZ (1) NZ244473A (de)
PL (1) PL170889B1 (de)
PT (1) PT100891A (de)
TW (1) TW215090B (de)
WO (1) WO1993006101A1 (de)
ZA (1) ZA927306B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5731307A (en) * 1994-09-30 1998-03-24 Pfizer, Inc. Neuroleptic 2,7-disubtituted perhydro-1h-pyrido 1, 2-A!pyrazines
WO1996010571A1 (en) * 1994-09-30 1996-04-11 Pfizer Inc. 2,7-SUBSTITUTED OCTAHYDRO-1H-PYRIDO[1,2-a]PYRAZINE DERIVATIVES
PA8469101A1 (es) * 1998-04-09 2000-09-29 Pfizer Prod Inc Ligandos azabiciclicos de receptores 5ht1
BRPI0408248A (pt) * 2003-03-12 2006-03-01 Pfizer Prod Inc derivados azabicìclicos de piridiloximetila e de benzisoxazol
CA2891122C (en) 2012-11-14 2021-07-20 The Johns Hopkins University Methods and compositions for treating schizophrenia
WO2014096212A1 (en) 2012-12-20 2014-06-26 Janssen Pharmaceutica Nv NOVEL TRICYCLIC 3,4-DIHYDRO-2H-PYRIDO[1,2-α]PYRAZINE-1,6-DIONE DERIVATIVES AS GAMMA SECRETASE MODULATORS
EP2945944B1 (de) 2013-01-17 2016-11-09 Janssen Pharmaceutica, N.V. Neuartige substituierte pyrido-piperazinon-derivate als gamma-sekretase-modulatoren
US10562897B2 (en) 2014-01-16 2020-02-18 Janssen Pharmaceutica Nv Substituted 3,4-dihydro-2H-pyrido[1,2-a]pyrazine-1,6-diones as gamma secretase modulators

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4804663A (en) * 1985-03-27 1989-02-14 Janssen Pharmaceutica N.V. 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
US4831031A (en) * 1988-01-22 1989-05-16 Pfizer Inc. Aryl piperazinyl-(C2 or C4) alkylene heterocyclic compounds having neuroleptic activity
NZ230045A (en) * 1988-08-05 1990-11-27 Janssen Pharmaceutica Nv 3-piperazinylbenzazole derivatives and pharmaceutical compositions
US4957916A (en) * 1988-08-05 1990-09-18 Janssen Pharmaceutica N.V. Antipsychotic 3-piperazinylbenzazole derivatives
MX19222A (es) * 1989-01-23 1993-12-01 Pfizer Agentes ansioliticos bis-aza-biciclicos
US4956368A (en) * 1989-07-24 1990-09-11 Bristol-Myers Company Metabolites and prodrug formulations of 8-[4-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]butyl]-8-azaspiro[4.5]decane-7,9-dione

Also Published As

Publication number Publication date
CZ281775B6 (cs) 1997-01-15
FI941377A0 (fi) 1994-03-24
PT100891A (pt) 1993-10-29
IL103204A0 (en) 1993-02-21
WO1993006101A1 (en) 1993-04-01
ES2096099T3 (es) 1997-03-01
CN1071167A (zh) 1993-04-21
NO941084D0 (no) 1994-03-24
GR3022483T3 (en) 1997-05-31
AU655071B2 (en) 1994-12-01
AU2460992A (en) 1993-04-27
FI941377A (fi) 1994-03-24
BR9206541A (pt) 1995-04-25
PL170889B1 (pl) 1997-02-28
MX9205385A (es) 1993-03-01
NZ244473A (en) 1995-04-27
JPH06506701A (ja) 1994-07-28
EP0607163A1 (de) 1994-07-27
IL103204A (en) 1996-05-14
DE69215886T2 (de) 1997-04-03
US5565453A (en) 1996-10-15
JPH08827B2 (ja) 1996-01-10
CZ395792A3 (en) 1994-05-18
HU9400851D0 (en) 1994-06-28
TW215090B (de) 1993-10-21
DE69215886D1 (de) 1997-01-23
MY108303A (en) 1996-09-30
CA2118936A1 (en) 1993-04-01
ZA927306B (en) 1994-03-24
EP0607163B1 (de) 1996-12-11
HUT71488A (en) 1995-11-28
NO941084L (no) 1994-03-24
ATE146178T1 (de) 1996-12-15

Similar Documents

Publication Publication Date Title
GB2270075B (en) Substituted 2-phenyl-3-methoxypropenoate fungicides
GR3017282T3 (en) Novel arylpyridazines, their manufacture, use and medicaments containing them.
IL99676A0 (en) Pyridine and pyridine n-oxide derivatives of diaryl methyl piperidines or piperazines,and compositions and methods of use thereof
ES2097174T3 (es) Derivados de la 2-ciclohexan-1-il amina.
ES2164639T3 (es) Quinoxalinas, procedimiento para su preparacion y su empleo.
DE69201748D1 (de) Pyrazinderivate.
DK0607163T3 (da) Neuroleptiske 2-substituerede perhydro-1-H-pyrido- 1,2-a pyraziner
ES8305344A1 (es) Un procedimiento para la produccion de un derivado de piperazina.
KR960004860B1 (en) Substituted pyridine-2,4-dicarboxylic acid compounds and the use thereof and medicaments
DK0777653T3 (da) Dihydropyridinderivater som bradykininantagonister
ES2080320T3 (es) Medicamento inmunoestimulante a base de glicopeptidolipidos polares de mycobacterium chelonae.
PT100001A (pt) Novos derivados glicosilicos inibidores da gluco-hidrolase uteis como agentes antidiabeticos
EP0509098A4 (en) Ataractic
FI990433A0 (fi) Neuroleptisiä perhydro-1H-pyrido(1,2-a)pyratsiineja
GB9022046D0 (en) New 2-substituted n,n'-ditrimethoxybenzoyl piperazines
FI933652A (fi) Foerfarande foer framstaellning av 1-osubstituerade 3-aminopyrroler